Acute respiratory distress syndrome (ARDS) followed by repair with lung remodeling is
observed in COVID-19. These findings can lead to pulmonary terminal fibrosis, a form of …

Since December 2019, coronavirus disease (COVID‐19) has rapidly swept the world. So far,
more than 30 million people have been infected and nearly one million have died. Although …

The rapid spread of coronavirus SARS-CoV-2 causing COVID-19 across the world poses a
major threat to the global health. The major cause of death in infected patients is severe …

Pulmonary fibrosis (PF) is a feared outcome of many pulmonary diseases which results in a
reduction in lung compliance and capacity. The development of PF is relatively rare, but it …

In December 2019, a novel coronavirus, SARS-CoV-2, appeared, causing a wide range of
symptoms, mainly respiratory infection. In March 2020, the World Health Organization …

The COVID‐19 pandemic rapidly spread around the world following the first reports in
Wuhan City, China in late 2019. The disease, caused by the novel SARS‐CoV‐2 virus, is …

The year 2020 is characterized by the COVID‑19 pandemic that has resulted in more than
half a million deaths in recent months. The high mortality is associated with acute severe …

COVID-19 is a highly contagious respiratory disease, which mainly affects the lungs.
Critically ill patients are easily complicated by cytokine storms, acute respiratory distress …

Abstract Coronavirus disease 2019 (COVID-19) has rapidly spread around the world
causing global public health emergency. In the last twenty years, we have witnessed several …

The COVID-19 fatality rate is high when compared to the H1N1pdm09 (pandemic Influenza
A virus H1N1 subtype) rate, and although both cause an aggravated inflammatory response …